|
OMIM |
Link |
Information gain |
01 |
|
ATHS
|
[NCBI]
|
0.0018657
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.00180498
|
|
|
APOB
|
[NCBI]
|
0.00129641
|
|
|
LPL
|
[NCBI]
|
0.00103465
|
|
|
coronary heart disease, susceptibility to, 1
|
[NCBI]
|
0.00101415
|
|
|
body mass index quantitative trait locus on chromosome 13
|
[NCBI]
|
0.00101415
|
|
|
coronary heart disease, susceptibility to, 3
|
[NCBI]
|
0.00101415
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 3
|
[NCBI]
|
0.00101415
|
|
|
body mass index quantitative trait locus on chromosome 7
|
[NCBI]
|
0.00101415
|
|
|
aortic aneurysm, familial thoracic 2
|
[NCBI]
|
0.000796434
|
|
|
body mass index quantitative trait locus on chromosome 11
|
[NCBI]
|
0.000796434
|
|
|
body mass index quantitative trait locus on chromosome 6
|
[NCBI]
|
0.000796434
|
|
|
CHDS8
|
[NCBI]
|
0.000714407
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.000661222
|
|
|
cholesterol level quantitative trait locus 1
|
[NCBI]
|
0.000661222
|
|
|
APOE
|
[NCBI]
|
0.000627225
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
0.000590318
|
|
|
earlobe crease
|
[NCBI]
|
0.000512606
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
0.00049998
|
|
|
TFPI
|
[NCBI]
|
0.000363522
|
|
|
PF4
|
[NCBI]
|
0.000310631
|
|
|
bilirubin, elevated concentrations of, in serum
|
[NCBI]
|
0.000307259
|
|
|
ACE
|
[NCBI]
|
0.000299046
|
|
|
PXE
|
[NCBI]
|
0.000264675
|
|
|
PON1
|
[NCBI]
|
0.000220986
|
|
|
SLE
|
[NCBI]
|
0.000220531
|
|
|
homocysteinemia
|
[NCBI]
|
0.000219665
|
|
|
LCAT
|
[NCBI]
|
0.000216068
|
|
|
FCHL
|
[NCBI]
|
0.000213142
|
|
|
arcus corneae
|
[NCBI]
|
0.000204738
|
|
|
ARH
|
[NCBI]
|
0.000193707
|
|
|
F3
|
[NCBI]
|
0.000181884
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
0.000179244
|
|
|
EGF
|
[NCBI]
|
0.000146813
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
0.000139462
|
|
|
CEACAM5
|
[NCBI]
|
0.000137886
|
|
|
CF
|
[NCBI]
|
0.000137805
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
0.000131987
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
0.000131987
|
|
|
MDD
|
[NCBI]
|
0.000124914
|
|
|
CETP
|
[NCBI]
|
0.000122555
|
|
|
KLK3
|
[NCBI]
|
0.000114397
|
|
|
APOA1
|
[NCBI]
|
0.000109336
|
|
|
sitosterolemia
|
[NCBI]
|
0.000107424
|
|
|
kawasaki disease
|
[NCBI]
|
0.000107424
|
|
|
ADCAD2
|
[NCBI]
|
0.000102319
|
|
|
low density lipoprotein, variation in molecular weight of
|
[NCBI]
|
0.000102319
|
|
|
MMP3
|
[NCBI]
|
9.93899e-05
|
|
|
LDLR
|
[NCBI]
|
9.82315e-05
|
|
|
NPPA
|
[NCBI]
|
9.62105e-05
|
|
|
GACI
|
[NCBI]
|
9.51982e-05
|
|
|
CRP
|
[NCBI]
|
8.4379e-05
|
|
|
FPLD2
|
[NCBI]
|
8.23673e-05
|
|
|
NOS3
|
[NCBI]
|
8.01433e-05
|
|
|
arterial occlusive disease, progressive, with hypertension, heart defects, bone fragility, and brachysyndactyly
|
[NCBI]
|
7.98756e-05
|
|
|
cholesteryl ester transfer protein deficiency
|
[NCBI]
|
7.14227e-05
|
|
|
PAI1
|
[NCBI]
|
6.88242e-05
|
|
|
MTHFR
|
[NCBI]
|
6.88074e-05
|
|
|
PON2
|
[NCBI]
|
6.69216e-05
|
|
|
myocardial infarction, susceptibility to, 2
|
[NCBI]
|
6.59438e-05
|
|
|
carotid intimal medial thickness 1
|
[NCBI]
|
6.59438e-05
|
|
|
ABCA1
|
[NCBI]
|
6.5751e-05
|
|
|
ITGA2
|
[NCBI]
|
6.38749e-05
|
|
|
AGT
|
[NCBI]
|
6.29886e-05
|
|
|
body mass index
|
[NCBI]
|
6.18772e-05
|
|
|
GFAP
|
[NCBI]
|
6.15399e-05
|
|
|
ITGB3
|
[NCBI]
|
5.89319e-05
|
|
|
CYBA
|
[NCBI]
|
5.50193e-05
|
|
|
THBS4
|
[NCBI]
|
5.41613e-05
|
|
|
TOMM40
|
[NCBI]
|
5.41613e-05
|
|
|
aging
|
[NCBI]
|
5.3663e-05
|
|
|
aspirin resistance
|
[NCBI]
|
5.16607e-05
|
|
|
EPO
|
[NCBI]
|
4.60239e-05
|
|
|
ATS
|
[NCBI]
|
4.55213e-05
|
|
|
LPA
|
[NCBI]
|
4.55103e-05
|
|
|
AVP
|
[NCBI]
|
4.53265e-05
|
|
|
MTR
|
[NCBI]
|
4.43299e-05
|
|
|
ESR1
|
[NCBI]
|
4.22828e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
4.11363e-05
|
|
|
PVRL2
|
[NCBI]
|
4.04233e-05
|
|
|
PRKCH
|
[NCBI]
|
4.04233e-05
|
|
|
DDX11
|
[NCBI]
|
4.04233e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
4.02115e-05
|
|
|
ADM
|
[NCBI]
|
3.76618e-05
|
|
|
stroke, ischemic
|
[NCBI]
|
3.69912e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
3.62835e-05
|
|
|
IL18
|
[NCBI]
|
3.58611e-05
|
|
|
APOA4
|
[NCBI]
|
3.52647e-05
|
|
|
ADORA1
|
[NCBI]
|
3.52647e-05
|
|
|
FUT3
|
[NCBI]
|
3.52647e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
3.50027e-05
|
|
|
PFHB1A
|
[NCBI]
|
3.49615e-05
|
|
|
SHBG
|
[NCBI]
|
3.45694e-05
|
|
|
GCCR
|
[NCBI]
|
3.40939e-05
|
|
|
ADIPOQ
|
[NCBI]
|
3.35429e-05
|
|
|
PLTP
|
[NCBI]
|
3.2217e-05
|
|
|
AHSG
|
[NCBI]
|
3.19297e-05
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
3.15863e-05
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
3.15863e-05
|
|
|
homocystinuria
|
[NCBI]
|
3.0744e-05
|
|
|
HNFJ
|
[NCBI]
|
3.01534e-05
|
|
|
TGD
|
[NCBI]
|
2.97059e-05
|
|
|
APOA2
|
[NCBI]
|
2.94608e-05
|
|
|
ABCG8
|
[NCBI]
|
2.94608e-05
|
|
|
HSPD1
|
[NCBI]
|
2.94608e-05
|
|
|
LRP6
|
[NCBI]
|
2.94608e-05
|
|
|
HP
|
[NCBI]
|
2.9054e-05
|
|
|
ACHE
|
[NCBI]
|
2.83781e-05
|
|
|
MB
|
[NCBI]
|
2.76588e-05
|
|
|
LRP1
|
[NCBI]
|
2.76588e-05
|
|
|
APOA5
|
[NCBI]
|
2.7502e-05
|
|
|
HCF2
|
[NCBI]
|
2.7502e-05
|
|
|
IL6
|
[NCBI]
|
2.70536e-05
|
|
|
temporal arteritis
|
[NCBI]
|
2.69408e-05
|
|
|
TNNI3
|
[NCBI]
|
2.58803e-05
|
|
|
SCARB1
|
[NCBI]
|
2.44982e-05
|
|
|
PCSK9
|
[NCBI]
|
2.44982e-05
|
|
|
MEF2A
|
[NCBI]
|
2.44982e-05
|
|
|
SELE
|
[NCBI]
|
2.44982e-05
|
|
|
ADK
|
[NCBI]
|
2.44982e-05
|
|
|
PAPPA
|
[NCBI]
|
2.44982e-05
|
|
|
RA
|
[NCBI]
|
2.34025e-05
|
|
|
BDNF
|
[NCBI]
|
2.3269e-05
|
|
|
HAE
|
[NCBI]
|
2.16047e-05
|
|
|
CCK
|
[NCBI]
|
2.14883e-05
|
|
|
ABL
|
[NCBI]
|
2.13639e-05
|
|
|
PTH
|
[NCBI]
|
2.12934e-05
|
|
|
CD14
|
[NCBI]
|
2.12783e-05
|
|
|
ECGF1
|
[NCBI]
|
2.12783e-05
|
|
|
UCP2
|
[NCBI]
|
2.09671e-05
|
|
|
hypertension, essential
|
[NCBI]
|
2.04435e-05
|
|
|
ALOX5AP
|
[NCBI]
|
2.04162e-05
|
|
|
CRH
|
[NCBI]
|
1.96457e-05
|
|
|
AR
|
[NCBI]
|
1.90365e-05
|
|
|
PPARA
|
[NCBI]
|
1.89752e-05
|
|
|
F12
|
[NCBI]
|
1.82393e-05
|
|
|
APOC2
|
[NCBI]
|
1.82393e-05
|
|
|
PPARG
|
[NCBI]
|
1.78931e-05
|
|
|
PLA2G7
|
[NCBI]
|
1.76189e-05
|
|
|
AMPD1
|
[NCBI]
|
1.76189e-05
|
|
|
ALS1
|
[NCBI]
|
1.71506e-05
|
|
|
SVAS
|
[NCBI]
|
1.69823e-05
|
|
|
VLDLR
|
[NCBI]
|
1.64978e-05
|
|
|
GP1BA
|
[NCBI]
|
1.64978e-05
|
|
|
MAPK14
|
[NCBI]
|
1.64978e-05
|
|
|
HHT
|
[NCBI]
|
1.55682e-05
|
|
|
alopecia, androgenetic
|
[NCBI]
|
1.55682e-05
|
|
|
TNFSF6
|
[NCBI]
|
1.55539e-05
|
|
|
ALDH2
|
[NCBI]
|
1.55075e-05
|
|
|
INS
|
[NCBI]
|
1.52706e-05
|
|
|
RBP4
|
[NCBI]
|
1.50531e-05
|
|
|
CEL
|
[NCBI]
|
1.46224e-05
|
|
|
VEGF
|
[NCBI]
|
1.45099e-05
|
|
|
KDR
|
[NCBI]
|
1.41598e-05
|
|
|
CAT
|
[NCBI]
|
1.34454e-05
|
|
|
CD40LG
|
[NCBI]
|
1.30974e-05
|
|
|
MG
|
[NCBI]
|
1.29371e-05
|
|
|
TNNT2
|
[NCBI]
|
1.27578e-05
|
|
|
MYH11
|
[NCBI]
|
1.24324e-05
|
|
|
HRG
|
[NCBI]
|
1.12536e-05
|
|
|
CD36
|
[NCBI]
|
1.07273e-05
|
|
|
IRS1
|
[NCBI]
|
1.04778e-05
|
|
|
XDH
|
[NCBI]
|
1.04617e-05
|
|
|
CMH
|
[NCBI]
|
9.1576e-06
|
|
|
MPO
|
[NCBI]
|
8.34685e-06
|
|
|
F2
|
[NCBI]
|
7.85584e-06
|
|
|
PCI
|
[NCBI]
|
7.85584e-06
|
|
|
HGF
|
[NCBI]
|
7.76349e-06
|
|
|
G6PD
|
[NCBI]
|
7.74881e-06
|
|
|
CHAT
|
[NCBI]
|
7.20885e-06
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
7.07515e-06
|
|
|
NPY
|
[NCBI]
|
7.03924e-06
|
|
|
LIPC
|
[NCBI]
|
6.93043e-06
|
|
|
TH
|
[NCBI]
|
6.92631e-06
|
|
|
CCL2
|
[NCBI]
|
6.78918e-06
|
|
|
UCN
|
[NCBI]
|
6.13086e-06
|
|
|
TTR
|
[NCBI]
|
5.85226e-06
|
|
|
LBP
|
[NCBI]
|
5.43291e-06
|
|
|
PCNA
|
[NCBI]
|
5.40687e-06
|
|
|
CPB2
|
[NCBI]
|
5.32514e-06
|
|
|
LEPR
|
[NCBI]
|
4.6302e-06
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
4.51722e-06
|
|
|
CP
|
[NCBI]
|
4.19052e-06
|
|
|
IGFALS
|
[NCBI]
|
4.10726e-06
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
4.02948e-06
|
|
|
GCK
|
[NCBI]
|
4.02585e-06
|
|
|
AD
|
[NCBI]
|
3.86978e-06
|
|
|
PG
|
[NCBI]
|
3.03194e-06
|
|
|
ADA
|
[NCBI]
|
2.86238e-06
|
|
|
CFH
|
[NCBI]
|
2.84985e-06
|
|
|
SERPINA6
|
[NCBI]
|
2.56703e-06
|
|
|
CDK2
|
[NCBI]
|
2.46065e-06
|
|
|
amyloidosis vi
|
[NCBI]
|
2.09241e-06
|
|
|
AT
|
[NCBI]
|
1.80101e-06
|
|
|
CASR
|
[NCBI]
|
1.69104e-06
|
|
|
TF
|
[NCBI]
|
1.40592e-06
|
|
|
LEP
|
[NCBI]
|
1.40012e-06
|
|
|
SOD2
|
[NCBI]
|
1.38935e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.22348e-06
|
|
|
TLR4
|
[NCBI]
|
1.05809e-06
|
|
|
PLG
|
[NCBI]
|
9.53734e-07
|
|
|
SPP1
|
[NCBI]
|
8.69682e-07
|
|
|
SDC2
|
[NCBI]
|
8.29965e-07
|
|
|
GAPDH
|
[NCBI]
|
6.84059e-07
|
|
|
hemophilia a
|
[NCBI]
|
5.40419e-07
|
|
|
COMT
|
[NCBI]
|
4.58537e-07
|
|
|
ALB
|
[NCBI]
|
4.37397e-07
|
|
|
RP
|
[NCBI]
|
4.05835e-07
|
|
|
TNF
|
[NCBI]
|
3.78793e-07
|
|
|
IL2
|
[NCBI]
|
2.92588e-07
|
|
|
VDR
|
[NCBI]
|
2.33353e-07
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
1.72242e-07
|
|
|
GIP
|
[NCBI]
|
7.58732e-08
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
3.62245e-08
|
|